A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients. [electronic resource]
Producer: 20141118Description: 638-643 p. digitalISSN:- 1569-8041
- Antimetabolites, Antineoplastic -- adverse effects
- Antineoplastic Agents -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carboplatin -- adverse effects
- Chemoradiotherapy
- Chemotherapy, Adjuvant
- Cisplatin -- adverse effects
- Disease-Free Survival
- Esophageal Neoplasms -- drug therapy
- Female
- Fluorouracil -- adverse effects
- Humans
- Male
- Middle Aged
- Paclitaxel -- adverse effects
- Radiotherapy, Adjuvant
- Retrospective Studies
- Treatment Outcome
- Tubulin Modulators -- adverse effects
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.